High throughput experimentation opportunities in development of topical medicines - 21/08/11
Robert King-Smith, PhD, Otto Mills, PhD, John Newsam, PhD, fqubed, Inc., San Diego, CA, United States; Samir Mitragotri, PhD, University of California, Santa Barbara, Santa Barbara, CA, United States
Le texte complet de cet article est disponible en PDF. P407 Poster will describe scientific innovations owned by fqubed, Inc. and licensed from third parties by fqubed, Inc. Robert Dominic King-Smith is an employee of and shareholder in fqubed, Inc. Otto Mills is an exclusive consultant to and has an option to acquire shares in fqubed, Inc. John Newsam is an employee of and shareholder in fqubed, Inc. Samir Mitragotri is an exclusive consultant to and shareholder in fqubed, Inc. 100% sponsored by fqubed, Inc. |
Vol 52 - N° 3S
P. P38 - mars 2005 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?